Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | VRTX | REGN | BMY |
| Company | Cara Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.7846 | 310.88 | 402.77 | 958.00 | 44.16 |
| High | 0.8315 | 312.73 | 407.59 | 962.10 | 44.62 |
| Low | 0.7700 | 297.52 | 401.02 | 950.27 | 43.78 |
| Last | 0.7900 | 299.48 | 402.50 | 958.64 | 43.90 |
| Change | +0.0118 | -11.81 | +1.42 | +1.64 | -0.09 |
| % Change | +1.52% | -3.79% | +0.35% | +0.17% | -0.20% |
| Volume | 353,700 | 4,717,000 | 1,462,400 | 351,900 | 9,126,800 |
| 20-Day Average Volume | 296,065 | 2,791,195 | 1,058,125 | 519,630 | 14,307,820 |
| Previous Close | 0.7782 | 311.29 | 401.08 | 957.00 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7410 | 273.78 | 398.34 | 910.88 | 47.10 |
| 20-Day Raw Stochastic | 69.66% | 62.66% | 69.30% | 96.02% | 6.79% |
| 20-Day Relative Strength | 51.10% | 62.69% | 48.38% | 59.47% | 29.02% |
| Weighted Alpha | -69.52 | +27.63 | +14.91 | +28.67 | -36.38 |
| Today's Opinion | 56% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 32% Sell | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.57% since 04/29/24 | +8.36% since 04/29/24 | +1.59% since 04/29/24 | +7.41% since 04/29/24 | -1.66% since 04/29/24 |
| Low | 0.7210 on 04/30/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 | 43.33 on 05/02/24 |
| High | 0.8315 on 05/06/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | -9.66% since 04/05/24 | +10.94% since 04/05/24 | -1.03% since 04/05/24 | +1.69% since 04/05/24 | -14.46% since 04/05/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.8800 on 04/08/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +36.94% since 02/06/24 | -5.25% since 02/06/24 | -3.28% since 02/06/24 | +2.22% since 02/06/24 | -10.88% since 02/06/24 |
| Low | 0.5150 on 02/08/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.1500 on 03/04/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -40.60% since 11/06/23 | +9.77% since 11/06/23 | +4.34% since 11/06/23 | +15.16% since 11/06/23 | -16.84% since 11/06/23 |
| Low | 0.5000 on 01/25/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 1.3200 on 11/07/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 42,542 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 54,667 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 3,000,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -32,340,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.74 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |